| AVF | Arteriovenous Fistula |
| AVG | Arteriovenous graft |
| BMS | Dare Metal Stents |
| BSI | Blood Stream infections |
| CRBI | Catheter Related Bloodstream Infection |
| CDC | Centers for Disease Control and Prevention |
| CMS | Centers for Medicare & Medicaid Services |
| CRAT | Catheter Related Atrial Thrombus |
| CT | Computed Tommography |
| CVS | Central Vein Stenosis |
| DCB | Drug Coated balloon |
| EAVF | Endovascular Arteriovenous Fistula |
| eAVG | Early cannulation Arteriovenous Graft |
| ESKD | End Stage Kidney Disease |
| FSG | Flair Endovascular Graft |
| FFI | Fistula First Initiative |
| FIR | Far Infrared Therapy |
| HAIDI | Hemodialysis Access Induced Distal Ischemia |
| HeRO | Hemodialysis Reliable Outflow |
| IDSA | Infectious Disease Society of America |
| K-DOQI | Kidney Disease Dialysis Outcomes and Quality Initiatives |
| KT/V | Dialysis Clearance index |
| MCP-1 | Monocyte Chemoattractant Protein 1 |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| NHSN | National Healthcare Safety Network |
| NTDS | Nephrologists Transforming Dialysis Safety |
| Omega-3 PUFAs | Omega -3 Polyunsaturated Fatty Acids |
| PTA | Percutaneous Transluminal Angioplasty |
| PTFE | Polytetrafluoroethylene |
| ePTFE | Expanded Polytetrafluoroethylene |
| RCT | Randomized controlled trial |
| RENOVA | Post-Approval Study for the FLAIR Endovascular Stent Graft |
| REVISE Vascular Access Revision with Viabahn Endoprosthesis vs. | Percutaneous Transluminal Angioplasty |
| SAR CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| TCC | Tunnelled Central Catheter |
| TCVO | Thoracic Central Vein Obstruction |
| TNF-Alpha | Tumor Necrosis Factor |
| t-PA | Tissue Plasminogen Activator |
| USRDS | United States Renal Data Systems |
| VSG | Viabahn Stent Graft |